Complexa: Complexa begins patient dosing in PRIMEx phase 2 trial of CXA─10 to treat pulmonary arterial hypertension

Complexa Inc announced dosing of the first patient in PRIMEx, a phase 2 clinical trial evaluating the safety and efficacy of two doses of the company's lead candidate, CXA─10, to treat pulmonary arterial